EFFECTIVENESS OF THE COMBINATION OF URINARY KALLIDINOGENASE (KALGEN 0.15 PNA) WITH EDARAVONE IN THE TREATMENT OF PATIENTS WITH BRAIN INFARCTION

Authors

  • Avezova Sadokat Urgench Branch of Tashkent Medical Academy, Urgench, Uzbekistan

DOI:

https://doi.org/10.62209/sewphc/art50135

Keywords:

clinical effect, edaravone, cerebral infarction, human urine kallidinogenase

Abstract

At the early stage of cerebral infarction, brain tissue in the area of cerebral infarction experiences metabolic acidosis due to severe hypoxic ischemia. Intracellular calcium is significantly overloaded, generating large amounts of free oxygen radicals. Oxygen free radicals are believed to be the main physiological and pathological basis of cerebral infarction. Ischemia-reperfusion injury occurs after cerebral infarction. Lipid-soluble radicals, hydroxyl radicals, and toxic free radicals based on superoxide anions are generated, which directly cause oxidative damage to intracellular lipids, proteins, and nucleic acids and can mediate an ischemic cascade reaction causing apoptosis and swelling of neuronal cells. Thus, the key to treating large cerebral infarction is to improve ischemia and inhibit and scavenge oxygen free radicals.

Published

2024-06-04

How to Cite

Avezova, S. (2024). EFFECTIVENESS OF THE COMBINATION OF URINARY KALLIDINOGENASE (KALGEN 0.15 PNA) WITH EDARAVONE IN THE TREATMENT OF PATIENTS WITH BRAIN INFARCTION. Journal of the Service of Sanitary and Epidemiological Welfare and Public Health of the Republic of Uzbekistan, 4(1), 5–9. https://doi.org/10.62209/sewphc/art50135